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Abstract
The flavones apigenin (49,5,7,-trihydroxyflavone) and luteolin (39,49,5,7,-tetrahydroxyflavone) are plant secondary
metabolites with antioxidant, antiinflammatory, and anticancer activities. We evaluated their impact on cell signaling
pathways related to insulin-resistance and type 2 diabetes. Apigenin and luteolin were identified in our U-2 OS (human
osteosarcoma) cell screening assay for micronutrients triggering rapid intracellular translocation of the forkhead box
transcription factor O1 (FOXO1), an important mediator of insulin signal transduction. Insulin reversed the translocation of
FOXO1 as shown by live cell imaging. The impact on the expression of target genes was evaluated in HepG2 (human
hepatoma) cells. The mRNA-expression of the gluconeogenic enzymes phosphoenolpyruvate carboxykinase (PEPCK) and
glucose-6-phosphatase (G6Pc), the lipogenic enzymes fatty-acid synthase (FASN) and acetyl-CoA-carboxylase (ACC) were
down-regulated by both flavones with smaller effective dosages of apigenin than for luteolin. PKB/AKT-, PRAS40-, p70S6K-,
and S6-phosphorylation was reduced by apigenin and luteolin but not that of the insulin-like growth factor receptor IGF-1R
by apigenin indicating a direct inhibition of the PKB/AKT-signaling pathway distal to the IGF-1 receptor. N-acetyl-L-cysteine
did not prevent FOXO1 nuclear translocation induced by apigenin and luteolin, suggesting that these flavones do not act
via oxidative stress. The roles of FOXO1, FOXO3a, AKT, sirtuin1 (SIRT1), and nuclear factor (erythroid-derived2)-like2 (NRF2),
investigated by siRNA knockdown, showed differential patterns of signal pathways involved and a role of NRF2 in the
inhibition of gluconeogenic enzyme expression. We conclude that these flavones show an antidiabetic potential due to
reduction of gluconeogenic and lipogenic capacity despite inhibition of the PKB/AKT pathway which justifies detailed
investigation in vivo.
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Introduction
The prevalence of type 2 diabetes (T2DM) and associated co-
morbidities is rising worldwide [1]. Obesity is a main risk factor [2]
and a feature of the metabolic syndrome that includes hyperten-
sion, dyslipidemia, glucose intolerance and insulin resistance [3].
The prevention of type 2 diabetes by life style intervention
including diet and exercise was successful [4]. To clarify the
preventive impact of macronutrient compositions, the effect of
supplemented isoenergetic diets differing in cereal fiber and
protein content on insulin sensitivity was investigated in over-
weight humans [5]. Consumption of higher quantities of vegetable
and a variety of fruits and vegetables containing bioactive
phytochemicals were associated with a reduced risk of T2D in a
case cohort study of EPIC-Norfolk [6]. Micronutrients such as the
polyphenol resveratrol (3,5,49-trihydroxystilbene) showed contro-
versial outcomes in different studies from improvement of insulin
sensitivity [7,8,9] to absence of any evidence of metabolic effects
[10]. Mediterranean diets rich in polyphenols were shown to
prevent T2DM [11].
To screen plant derived micronutrients for their potential
antidiabetic activity we analyzed their impact on the intracellular
distribution of FOXO1 indicating the state of insulin signaling.
The forkhead box transcription factor FOXO1 undergoes nuclear
exclusion induced by insulin via the phosphatidylinositol 39-kinase
(PI3K)-PKB/AKT pathway which leads to an inactivating
phosphorylation of FOXO1 at Ser256 (gatekeeper), Thr24, and
Ser319 reducing tight DNA-binding and enhancing the binding of
the protein 14-3-3 followed by nuclear export and cytoplasmic
retention of FOXO1 [12]. FOXO activity and intracellular
localization is also controlled by the acetylation/deacetylation
state [13,14,15]. Deacetylation of FOXO by the silent information
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regulator 2 (Sir2) mammalian ortholog sirtuin 1 (SIRT1) makes
FOXO available for activating monoubiquitinylation [16] and
inactivating polyubiquitinylation by E3 ubiquitin-protein ligase
MDM2 inducing FOXO intranuclear and nuclear-cytoplasmic
shuttling respectively [17]. These multiple upstream pathways
regulating FOXO activity through posttranslational modifications
(PTMs) and nuclear-cytoplasmic shuttling enable FOXOs to act as
signaling integrators for homeostasis maintenance, orchestrating
metabolic target genes for gluconeogenesis, food intake and redox
balance, protein homeostasis including autophagy, cell cycle
arrest, and apoptosis in response to metabolic stress, oxidative
stress and growth factor deprivation by differential downstream
transactivations [18]. Localization of the forkhead box transcrip-
tion factor FOXO in the nucleus is itself indicative of, but not
identical to, transcriptional activity, as several FOXO regulators
also display dynamic localization [18]. Using a FOXO1-translo-
cation assay, we found highest translocation activity induced by
apigenin (49,5,7,-trihydroxyflavone) and luteolin (39,49,5,7,-tetra-
hydroxyflavone) in our screening of a library of plant micronu-
trients. Luteolin is one of the most common polyphenolic
flavonoids present in many edible plants such as carrots, peppers,
celery, olive oil, peppermint, thyme, rosemary, oregano, lettuce,
pomegranate, artichoke, cucumber, lemon, beets, cabbage,
cauliflower, spinach, parsley, and green tea [19]. A high dietary
intake of luteolin was associated with a lowered risk of acute
myocardial infarction [20]. Many luteolin containing plants
possess antioxidant properties associated with the capacity to
scavenge reactive oxygen and nitrogen species (ROS, RNS) to
inhibit pro-oxidant enzymes and to induce antioxidant enzymes
observed in vitro and in vivo by this flavonoid as reviewed by
Lopez-Lazaro [19]. Regarding anti-inflammatory activities, lute-
olin was identified as the most potent flavonoid in inhibiting TNF-
alpha release from macrophages, in blocking lipopolysaccharide
(LPS)-induced activation of the nuclear factor-kappa B (NF-kappa
B) and IL-6 production by inhibition of the JNK and AP1-
signaling pathways [21]. Apigenin with three phenolic hydroxyl
groups has a lower TEAC (Trolox equivalent antioxidant capacity)
than luteolin bearing four OH-groups including an ortho-
dihydroxy structure in the B ring which is essential as well as
the 2,3-doublebond in conjugation with the 4-oxo function in the
C ring and the 5- and 7-OH groups in ring A for effective free
radical scavenging by dissociation of hydroxyl functions [22]. Like
luteolin, apigenin is a natural plant flavone abundantly common in
chamomile, parsley, onions, grapefruit, oranges and plant derived
beverages with antioxidative and antiproliferative effects in human
cancers of the breast, cervix, colon, lung, ovary, prostate, skin,
thyroid, and liver [23]. With FOXO1 not only as the endpoint of
IGF signaling but also of insulin signaling via the PI3K-AKT
pathway, we focused our investigations on the metabolic effects of
apigenin and luteolin to analyze their roles in modulating insulin
signal transduction which is disturbed in insulin resistance and
T2D. To date, there has been no report on the regulation of
gluconeogenesis and lipogenesis by flavones.
Health promoting effects on preclinical diabetes by reduction of
blood glucose by attenuation of gluconeogenesis, which is elevated
during insulin resistance, have not been described for flavones to
date. We found apigenin and luteolin to induce FOXO1
translocation, which plays a key role in insulin signaling, using
stably transfected human U-2 OS cells expressing FOXO1-GFP.
For analysis of FOXO-target gene expression, we analyzed
HepG2 cells expressing hepatic PEPCK and G6Pc and showed
for the first time a down-regulation of mRNA of key gluconeo-
genic enzymes by apigenin and luteolin in a dose dependent
manner thereby providing an antihyperglycemic effect. The gene
expression of the lipogenic enzymes FASN and ACC was reduced
by these flavones potentially preventing hepatic steatosis. To
identify different signaling pathways involved in these effects, gene
expression analyses were performed after knock down of the
transcription factors NRF2, FOXO3a, FOXO1, the downstream
deacetylase SIRT1 and the upstream modulating kinase AKT as
well. Remarkably, apigenin and luteolin also reduced the insulin-
induced phosphorylation of AKT, mammalian target of rapamy-
cin (mTOR), p70S6K, the ribosomal protein S6, and the proline-
rich AKT/PKB substrate 40 kDa (PRAS40) indicating an
inhibition of the AKT signaling pathway.
Material and Methods
Chemicals
Apigenin ($97% purity, from parsley), luteolin ($98% purity),
isokaempferide ($90% purity), kaempferol ($90% purity), quer-
cetin ($95% purity), and resveratrol ($99% purity) were
purchased from Sigma-Aldrich and solubilized in dimethyl
sulfoxide (DMSO). In all experiments the final concentration of
DMSO did not exceed 0.5%. Insulin (human recombinant)
10 mg/ml solution in 4-(2-hydroxyethyl)-1-piperazineethanesulfo-
nic acid (HEPES) pH 8.2 and N-acetyl-L-cysteine (NAC) were
obtained from Sigma-Aldrich.
Preparation of solutions
Apigenin, luteolin, isokaempferide, kaempferol, quercetin, and
resveratrol were dissolved in DMSO to obtain a 20 mM stock
solution and diluted in medium for cell culture (DMEM for U-2
OS and EMEM for HepG2) to obtain 100 mM flavone as highest
concentration for stimulation. Further dilutions down to 0.5 mM
for dose-response experiments were performed with addition of
DMSO to keep its concentration stable at 0.5%, which was used
for mock stimulation in the control cells as well. Insulin was diluted
from 10 mg/ml ( = 1,722 mM) in medium to obtain 100 nM final
concentration for stimulation of cells in culture.
Cell lines and culture
U-2 OS (human osteosarcoma cell line) was purchased from
ECACC (European Animal and Cell Collection). Cells were
maintained using DMEM (Dulbecco’s Modified Eagle Medium)
with 4.5 g/L D-glucose, 3.7 g/L NaHCO3, stable glutamine, and
Na-pyruvate supplemented with 10% FBS (Fetal Bovine Serum)
and kept viable in a humidified atmosphere, at 37uC, 5% CO2.
HepG2 (hepatocellular carcinoma, human) was purchased from
ECACC and cultivated in EMEM (EBSS Eagle’s Minimum
Essential Medium with Earle’s Balanced Salt Solution), stable
glutamine, 2.2 g NaHCO3, 1 g/L D-glucose, supplemented with
1% NEAA (Non-Essential Aminoacids) and 10% FBS purchased
from Biochrom Germany. A human embryonic kidney (HEK) cell
line stably transfected with the human IGF-1R was a gift from
Prof. J. Frystyk, institute of Clinical Medicine, Aarhus University,
Denmark. Cells were maintained in DMEM (Biochrom AG,
Berlin, Germany) supplemented with 10% fetal bovine serum, 1%
penicillin/streptomycin, 1% hygromycin and 0.1% geneticin. For
passaging of cells TrypLE express from life Technologies was used.
Cell treatment with apigenin, luteolin, isokaempferide,
kaempferol, resveratrol, and insulin
Before incubation of cells with test compounds, growth of sub-
confluent U-2 OS cells was calmed down for 16 h by reduction of
10% FBS to 2% FBS and further to 0% FBS in DMEM for 1 h
starvation. HepG2 cells were starved for 16 h in EMEM with 1 g/
L glucose without FBS. Stimulation of cells was performed in FBS-
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free medium with apigenin, luteolin, isokaempferide, kaempferol,
and resveratrol dissolved in DMSO and diluted in medium (final
DMSO concentration #0.5%). Control cells were incubated with
the same amount of DMSO (mock stimulation). Insulin was
applied to DMSO pretreated and untreated cells.
Cell transfection
Transfection of sub-confluent cells with DNA plasmids was
performed with Lipofectamine 2000 in Opti-MEM reduced serum
medium from Invitrogen according to the manufacturer’s
description. The vector for stable transfection of U-2 OS for
constitutive expression of GFP- labeled FOXO1 was pEGFP-N1
with an insertion of FOXO1 cDNA. Zhang et al. [24] subcloned
the wild type sequence reported in GenBank AF032885 for full
length human FKHR=FOXO1 complete coding sequence (CDS)
+ 224 base pairs (bp) of the 59- untranslated region (UTR) and
133 bp of 39-UTR into the XbaI-AccI site in pAlter.MAX from
Promega for site-directed mutagenesis converting sequences
coding for serine-256, serine-319 and threonine 24 to alanine
coding sequences. This was cloned in frame with the CDS of GFP
into the BGLII-SalI site in pEGFP-N1 from Clontech for studies
of cellular trafficking of mutated forms of FKHR. These constructs
encoding mutant FKHR with the stop codon removed, followed
by the C-terminal green fluorescent protein (GFP) tag (pEGFP-
FOXO1mut) and pAlter.MAX -FOXO1wt (wild type) were kindly
provided by Terry Unterman (University of Illinois at Chicago,
USA). We excised the region with 3 mutations of FOXO1 from
pEGFP-FOXO1mut by restriction with HindIII and BstEI and
inserted the HindIII-BstEI-fragment without mutations from
pAlter.MAX-FOXO1wt. The resulting pEGFP-FOXO1 con-
tained the complete FOXO1 CDS + 33 bp of the 59-UTR and
according to our sequencing data the last triplet of the CDS ggc
coding for glycine in front of the stop-codon tga was exchanged to
tcg coding for serine followed by 33 bp coding for 11 connecting
amino acids in front of the CDS of GFP.
Following transfection of pEGFP-FOXO1, U-2 OS cells were
grown in DMEM + 10% FBS and Geneticin G418 sulfate from
Calbiochem (0.4 mg/ml) was added after 48 h for selection of
genetically engineered cells carrying the plasmid with encoded
resistance. Separating cells over 3 passages by dilution up to 1:108
in 96-well plates coated with Poly-D-lysine starting with growth in
conditioned medium resulted in homogeneous cell colonies
expressing FOXO1-GFP, analyzed by fluorescence microscopic
live cell imaging used for selection of GFP-positive cells.
Transfection of silencing RNA (siRNA) was performed using
DharmaFECT4 (D4) transfection reagent proposed for HepG2
transfection by Dharmacon Thermo scientific with ON-TAR-
GETplus SMARTpool siRNA including four SMARTselection-
designed siRNAs pooled for efficient knockdown of each target:
FOXO1, FOXO3a, AKT, SIRT1, NRF2, and NT (siGENOME





















and Non-Targeting Sequences NT were:
#2 59-UAAGGCUAUGAAGAGAUAC-39; #3 59-AUGUA-
UUGGCCUGUAUUAG-39;
#4 59-AUGAACGUGAAUUGCUCAA-39; #5 59-UGGUU-
UACAUGUCGACUAA-39. Transfections of HepG2 were per-
formed 24 h after seeding 100,000 cells per well of 12 well plates in
EMEM with FBS 10%. SiRNAs were dissolved and diluted
according to the manufacturer’s description. Transfection reagent
D4 was diluted in EMEM without FBS, incubated 59 at RT and
mixed with siRNAs followed by 209 incubation at RT. HepG2
cells obtained fresh EMEM with 10% FBS before transfection.
Cells were treated with transfection mixtures of D4 and NT-
siRNA for transfection controls, or D4 and smart pool siRNAs for
FOXO1, FOXO3a, AKT, SIRT1, NRF2 or mixtures of
FOXO1/FOXO3a, FOXO1/NRF2, FOXO1/AKT, FOXO1/
SIRT1, FOXO3a/SIRT1 and AKT/NRF2 for specific target
knockdowns in triplicates. Because 24–48 h was recommended for
Table 1. Primer sequences for qRT-PCR.
Primers for qRT-PCR targets Oligo forward Oligo sequence (59 to 39) Oligo reverse Oligo sequence (59 to 39)
60S ribosomal protein L32 hRLP-32_fwd CAACGTCAAGGAGCTGGAAGT hRLP-32_rev TTGTGAGCGATCTCGGCAC
Acetyl-CoA-carboxylase hACC_fwd TCGCTTTGGGGGAAATAAAGTG hACC_rev ACCACCTACGGATAGACCGC
Fattyacid-synthetase hFASN_fwd AGACACTCGTGGGCTACAGCAT hFASN_rev ATGGCCTGGTAGGCGTTCT
Forkhead box O1 hFOXO1_fwd GGCTGGAAGAATTCAATTCGTC hFOXO1_rev ACCCTCTGGATTGAGCATCCAC
Forkhead box O3 hFOXO3_fwd CATGGCAAGCACAGAGTTGGA hFOXO3_rev CGGCTTGCTTACTGAAGGTGAC
Glucose-6-phosphatase hG6Pc_fwd CCCCTGATAAAGCAGTTCCCT hG6Pc_rev ATACACCTGCTGTGCCCATG
Nuclear factor (erythroid derived)-like2 hNRF2_fwd AACTACTCCCAGGTTGCCCA hNRF2_rev CAAGTGACTGAAACGTAGCCGA
Phosphoenolpyruvat-carboxykinase hPEPCK_fwd AAGTATGACAACTGCTGGTTGGC hPEPCK_rev ATAACCGTCTTGCTTTCGATCCT
Proteinkinase B/AKT hAKT1_fwd GCTTCTATGGCGCTGAGATTGT hAKT1_rev TGATCTTAATGTGCCCGTCCTT
Sirtuin1 hSIRT1_fwd ATGCTGGCCTAATAGAGTGGCA hSIRT1_rev CCTCAGCGCCATGGAAAAT
Primer design by Primer Express for qRT-PCR based on human mRNA sequences.
doi:10.1371/journal.pone.0104321.t001
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RNA- knockdown and 48–96 h for protein-knockdown, we
exchanged the medium to EMEM without FBS 32 h after
transfection followed by 16 h starvation before treatment of the
transfected cells with DMSO 0.1%, apigenin 20 mM and luteolin
20 mM for 24 h.
RNA isolation and real-time PCR
Extraction of RNA was performed with the Nucleospin RNA II
total RNA isolation kit from Machery-Nagel following treatment
of cells with compounds as per figure legends. In each 1 mg of
RNA was reverse transcribed with the High Capacity cDNA
Reverse Transcription Kit from Applied Biosystems and quanti-
tative real time PCR (qRT-PCR) was performed with the Power
SYBR green PCR Master Mix from Applied Biosystems using the
Vii7 Real-Time PCR System from Life Technologies. Each
reaction was carried out in triplicates, using a standard curve with
the relevant cDNA for each primer pair. Primers for qRT-PCR
were designed using Primer Express and purchased from
Invitrogen. Primer sequences used for real time PCR are
summarized in Table 1. Amplification of 60S ribosomal protein
L32 (RPL-32) housekeeping gene was performed for normaliza-
tion of target gene expression.
Path Scan intracellular signaling array
We used the PathScan Intracellular Signaling Array Kit from
Cell Signaling Technology with a fluorescent readout for
simultaneous detection of 18 signaling molecules when phosphor-
ylated such as AKT(Thr308), AKT(Ser473), AMPKa(Thr172),
mTOR(Ser2448), p70S6K(Thr389), S6 Ribosomal Protein(-
Ser235/236), PRAS40(Thr246), GSK-3b(Ser9), BAD(Ser112),
HSP27(Ser78), p53(Ser15), p38(Thr180/Tyr182), ERK1/
2(Thr102/Tyr204), Stat1(Tyr701), Stat3(Tyr705) or cleaved
PARP(Asp214) and Caspase-3(Asp175). Lysates were obtained
from HepG2 cells treated with DMSO 0.1%, insulin 100 nM,
insulin + DMSO, apigenin 20 mM, luteolin 20 mM, insulin +
apigenin and insulin + luteolin for 309, using the provided 16cell
lysis buffer supplemented with phenylmethylsulfonyl fluoride
(PMSF) to a final concentration of 1 mM and phosphatase-
inhibitor from Roche (1 tablet per 10 ml as recommended).
Following ultrasonication and centrifugation the clear supernatant
was used for the determination of protein contents with the BCA
protein assay kit from BIO RAD. Samples were diluted in array
diluent buffer to 1 mg/ml. Glass slides with antibody spotted
nitrocellulose-pads were connected with a multi-well gasket for
blocking each pad with 100 ml array blocking buffer per well for
15 minutes followed by 16 h incubation at 4uC with each 75 ml
diluted lysate. After four washing steps with each 100 ml array
wash buffer pads were incubated with 75 ml of the provided
detection antibody cocktail for 1 h at RT, washed four times and
incubated with 75 ml DyLight 680-linked streptavidin for 30 min-
utes under light protection. After four washing cycles each 59 the
gasket was removed, the slide rinsed in deionized water and dried
completely. Slides were scanned with the LI-COR Biolumines-
cence imager and analyzed using ODYSSEY software.
IGF-1 kinase receptor cell based activation assay
IGF-1 receptor phosphorylation was investigated as described
[25] by a kinase receptor activation assay (KIRA) using a human
embryonic kidney (HEK) cell line stably transfected with the
human IGF-1R. Cells were maintained in DMEM supplemented
with 10% fetal bovine serum, 1% penicillin/streptomycin, 1%
hygromycin and 0.1% geneticin for 24 h. The medium was
changed to DMEM with 0.1% human serum albumin (HSA) for
further 24 h. After 48 h of cell culture maintenance, the cells were
stimulated with different concentrations of human recombinant
IGF-1 for 16 min at 37uC to obtain a standard curve. To clarify
the effect of apigenin on IGF-1 receptor phosphorylation, the cells
were stimulated with different concentrations of IGF-1 with or
without apigenin 20 mM. Stimulated cells were lysed and
transferred to a normal ELISA-sandwich assay using a mouse
monoclonal IGF-1R antibody as a capture antibody and anti-
mouse horseradish peroxidase-conjugated anti-phosphotyrosine
monoclonal antibody as a detection antibody. All measurements
were performed in duplicates.
Cell viability assay
A CellTiter96 Aqueous Cell Proliferation assay from Promega
was used to test the viability of HepG2 during 24 h incubation
with apigenin and luteolin in the range of 1–100 mM including
0.5% of DMSO solvent, DMSO 0.5% alone and without DMSO.
20,000 HepG2 cells grown in MEM + 10% FBS were seeded per
well in a clear 96-well plate without coating from Greiner. 5 h
after seeding medium was exchanged using MEM without FBS for
16 h starvation. Apigenin and luteolin were added in triplicates
per concentration 1 mM, 2 mM, 5 mM, 10 mM, 20 mM, 50 mM,
100 mM and cells incubated for 24 h. Following application of
20 mM (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy phenyl)-
2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS)/phenazine
methosulfate (PMS - electron coupling reagent) per well, cells
were incubated 4 h at 37uC under 0.5% CO2 and the optical
density of the MTS bioreduction product formazan was measured
after 4 h at 490 nm with the Wallac VICTOR plate reader.
FOXO1 translocation assay
Transfected U-2 OS cells with pEGFP-FOXO1 stably express-
ing wild type FOXO1 tagged at the C-terminus with GFP were
used for FOXO1-GFP visualization by fluorescence microscopy.
10,000–15,000 cells/100 ml DMEM + 10% FBS per well were
seeded in black, clear bottom 96-well plates from BD coated with
poly-D-lysine. After 6 h medium was exchanged to DMEM + 2%
FBS and after 16 h to DMEM without FBS for 1 h of starvation
before treatment of cells with test substances such as apigenin,
luteolin, isokaempferide, kaempferol, quercetin, resveratrol, and
other plant derived micronutrients solely and/or in combination
with insulin in triplicates. Life cell imaging was performed with the
Zeiss ‘‘Axio Observer.Z1’’ inverted microscope in a cell incubation
chamber. Images with a filter for GFP were taken every minute up
to 1 h to follow the intracellular translocation of FOXO1-GFP.
For defining nuclear areas, cells were fixed with 4% paraformal-
dehyde in phosphate buffered saline (PBS) and nuclei stained with
49,6-diamidino-2-paraphenylindole (DAPI) from Invitrogen
200 nM in 0.3% TritonX-100 for 30 min, washed in PBS, and
exposed with the filter for DAPI as well. For quantification of GFP
signals we used the BD Pathway 435 Bioimager from Becton
Dickinson with a high performance laser-based autofocus for
automated imaging of each of 96 wells with two exposures in the
GFP-channel for separate detection in nuclear and cytoplasmic
regions and one in the DAPI-channel. Using BD AttoVision
version 1.6/435, images were acquired for GFP-Nuc and GFP-
Cyto with exposures for 0.5 seconds each and for DAPI with
0.05 seconds per probe cycle for each well with a montage capture
setup 262. For the multi-well plate setup a compound macro
(nuclear translocation GFP GFP DAPI 96 well) was created
resulting in a macro setup starting with a laser autofocus step
followed by a cycle with three exposures: twice in the channel for
GFP and once in the DAPI channel repeated for each well. A
treatment plate map with definitions of substances and concen-
trations used for stimulations of cells per well in quadruplicates was
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Figure 1. FOXO1-GFP translocation in stably transfected U-2 OS (human osteosarcoma cells). Intracellular localization of the forkhead
box transcription factor O1 labelled with green fluorescent protein FOXO1-GFP visualized by fluorescence microscopy after nuclear staining with
DAPI (colour coded red). Merged images in left panel: Cytoplasm green from FOXO1-GFP, nuclei redRorangeRyellowRgreen depending on GFP
overlay from FOXO1-GFP accumulated in nuclei (A–C). Right panel GFP images (A9–C9). (A, A9) Transfected U-2 OS cells with pEGFP-FOXO1 (after 1 h
starvation in DMEM without FBS) treated with DMSO 0.15% (control) 2 h with cytoplasmic and perinuclear localization of FOXO1-GFP. (B, B9) Apigenin
30 mM in 0.15% DMSO induced nuclear accumulation of FOXO1-GFP. (C, C9) Luteolin 30 mM in DMSO 0.15% induced translocation of FOXO1-GFP
from cytoplasm into nuclei in nearly all transfected U-2 OS cells with stable expression of GFP tagged FOXO1.
doi:10.1371/journal.pone.0104321.g001
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set up to enable analysis of each experiment. Processing was
performed under flat field correction and background subtraction.
For the segmentation of cells we used the provided method ‘‘Cyto-
Nuc Ring Band’’ with the shape ‘‘Ring (2outputs) Band’’ analyzing
the DAPI channel for defining nuclear areas. In each exposure
nuclei were split by watershed and an erosion factor of 7, scrapped
to object pixels 400–2,000 and the inner nuclear region output
reduced by an erosion width of 1 pixel. The cytoplasmic ring was
obtained by a dilation of 4 pixels and an erosion of 3 pixels with
an outer region output for a cytoplasmic area around the nucleus
in a band excluding nuclear-cytoplasmic boundary from measure-
ment of GFP intensities. Further analyses were performed with the
BD Image Data Explorer from BD Biosciences using the measured
regions of interest (Roi)Summary Re-analysis and treatment plate
map as data sources to create the explorer data file. In the data
management the treatment plate map was connected with the
RoiSummary, wells for analysis selected, in parameter arithmetic a
new parameter (GFP_Nuc_intensity/GFP_Cyt_intensity) as (Ra-
tio Nuc/Cyt) added, and in constrains for cytoplasm GFP-
intensities selected .800 above the background to exclude cells
without FOXO-GFP expression and for nuclei ,4,000 to exclude
artifacts. Ratios Nuc/Cyt were evaluated in charting by bar charts
with average parameter values per well, standard error over
selected wells, and error bar charts by dose defined in treatment
plate map. Ratios ,1 represented cells with a predominant
cytoplasmic localization of FOXO1-GFP and ratios .1 showed a
nuclear accumulation of FOXO1. By normalization versus
untreated cells, an induced translocation factor was calculated
for treatment substances.
Data handling and statistical analysis
All fluorescent microscopic data were analyzed using charts data
from the BD image data explorer. For quantification of
immunodetections, integrated intensities were corrected by
background subtraction and normalized to untreated control cell
phosphorylation of each signaling molecule duplicates in PathScan
analyses. Relative mRNA expression was measured by cDNA
amplification quantified with ViiA7 RUO software for real time
PCR system version 1.2 in comparison to standard c-DNA
dilution for amplification. Data were evaluated by analysis of
variance (ANOVA) including Levene statistic as test of homoge-
neity of variances for the choice of Post Hoc Tests (Bonferroni for
equal and Dunnett T3 for unequal variances) or by 2-tailed
unpaired student’s T Tests (using IBM SPSS statistics version 20),
with significance accepted at values of p,0.05. EC50 or IC50
were calculated from sigmoidal dose-response (variable slope) by
nonlinear regression of transformed data (GraphPad Prism 6).
Results
FOXO1 translocation in U-2 OS cells stably transfected
with pEGFP-FOXO1
In analyses of micronutrients screened in concentrations of 1, 10
and 100 mM with our FOXO1 translocation assay, we calculated
Figure 2. Dose-dependent induction of FOXO-GFP translocation by apigenin and luteolin, competition by insulin. Stably transfected
human osteosarcoma cells with FOXO1-GFP (U2OS-FOXO1-GFP) treated with apigenin (A), luteolin (B) 1–100 mM for 2 h 2/+ addition of insulin
100 nM after 30 minutes. Cells were fixed and stained with DAPI. Fluorescence microscopic detection of nuclei, segmentation of cells, quantification
of GFP intensities measured in nuclear and cytoplasmic areas and calculation of the GFP-ratio nucleus/cytoplasm were performed for all FOXO-GFP
expressing cells by BD Image Data Explorer. Nonlinear regression was performed with Graph Pad Prism. Results are presented as mean 6 SEM of
quadruplets with *(p,0.05) significant differences vs. control (ANOVA + Post Hoc Tests). (A) Dose-dependent accumulation of FOXO1 in nuclei
induced by apigenin 1–100 mM shown as mean ratio of FOXO1 nucleus/cytoplasm + SEM (n= 4) *p,0.05 (Dunnett T3) and EC50= 13 mM calculated
by nonlinear regression from sigmoidal dose response. Reversion by insulin 100 nM induced FOXO1 translocation from nuclei into the cytoplasm. (B)
Luteolin induced FOXO1 nuclear accumulation shown as mean ratio of FOXO1 nucleus/cytoplasm + SEM (n = 4) *p,0.05 (Bonferroni) with
EC50= 12 mM and competing insulin effect.
doi:10.1371/journal.pone.0104321.g002
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specific FOXO1 translocation factors as ratios FOXO1-GFP
Nuc/Cyt after 2 h-treatment of U-2 OS normalized to DMSO
mock treated cells. High FOXO1-import factors were obtained for
each 100 mM of different polyphenols such as luteolin (3.1),
apigenin (2.6), isokaempferide (2.3), kaempferol (2.2), quercetin
(2.0), and resveratrol (1.6). For the most potent flavones luteolin
and apigenin, induction of intranuclear accumulations of
FOXO1-GFP is shown in our stably transfected U-2 OS after
2 h treatment with each 30 mM (Fig. 1A–C).
Dose response and reversibility of FOXO1 translocation
by insulin
FOXO1 translocation was induced dose-dependently by
apigenin (Fig. 2A) and luteolin (Fig. 2B). Insulin 100 nM was able
to reverse FOXO1 nuclear accumulation induced by apigenin 1–
50 mM nearly completely, when applied 309 following apigenin
treatment (Fig. 2A). FOXO1 accumulation induced by luteolin
30–100 mM was only partially reversible by insulin 100 nM at
higher concentrations above 20 mM (Fig. 2B). Our results show
the reversibility of FOXO1 translocation by both flavones in the
presence of insulin to different degrees depending on one
additional hydroxyl group for luteolin in position 39 of ring B of
the flavonoid structure. Kinetics of FOXO1 translocation
Time-dependent FOXO1 translocation was shown by life cell
imaging of U-2 OS and Hep G2. FOXO1-GFP translocation was
observed in living cells during incubation for 1 h with apigenin,
luteolin, and resveratrol and is shown for apigenin (U-2 OS) and
luteolin (Hep G2) 10 mM (Fig. 3A and B, respectively). Apigenin
10 mM induced the highest nuclear accumulation with fast kinetics
from 59–309 following application. Addition of insulin 100 nM at
this time point of 309 resulted in a complete export of FOXO1
during the following 209 to the level before apigenin application
(Fig. 4). Similar kinetics were observed with luteolin and
resveratrol although differing in a less complete insulin reversibility
(see Fig. 2B for less reversibility shown in dose response for
luteolin).
Role of ROS in triggering apigenin- and luteolin induced
FOXO1 translocation
Analyses were performed in the presence of antioxidants to test
whether flavone induced FOXO1 translocation could be depen-
dent on oxidative stress. After preincubation of U-2 OS cells with
the antioxidant N-acetyl-L-cysteine (NAC) 5 mM and 25 mM for
309, the induction of FOXO1-GFP translocation by apigenin
30 mM during 2 h incubation was not disturbed resulting in a 2-
fold accumulation in nuclei. Unexpectedly, NAC restricted the
competing export of FOXO1 by insulin 100 nM in a dose
dependent manner (Fig. 5A). The higher import-factor of 2.5
induced by luteolin 30 mM was reduced by insulin to 1.2. In the
presence of NAC 5 mM the nuclear accumulation factor was
reduced slightly to 2.3 and NAC 25 mM abolished the insulin
effect (Fig. 5A). These results show that apigenin and luteolin did
not induce FOXO1 import into nuclei by provoking oxidative
stress while the insulin induced export of FOXO1 depended on
the oxidative status of the cell and was reduced by increasing
antioxidants.
Treatment for 24 h with apigenin 30 mM showed a lower rate
of FOXO1 nuclear accumulation of 1.5-fold, which was enhanced
after pretreatment with NAC 5 mM to 1.6-fold and with NAC
25 mM to 2-fold accumulation (Fig. 5B). During 24 h of
incubation, FOXO1 seemed to undergo an equilibrium between
nuclear import and export, and the 2-fold nuclear accumulation
seen after 2 h could be maintained only in the presence of NAC
25 mM, which was able to reduce FOXO1 export induced by
insulin as well. The reduction of apigenin induced FOXO1
accumulation by insulin was not complete after 24 h, diminished
in the presence of NAC 5 mM and abolished with NAC 25 mM
(Fig. 5B). 24 h luteolin 30 mM resulted in a 1.6-fold FOXO import
which increased to 1.9- and 2-fold in the presence of NAC 5 mM
and 25 mM respectively, the latter not being reduced by insulin
(Fig. 5B). These data show that the insulin induced FOXO1
translocation from the nucleus to the cytoplasm was disturbed by
prevention of oxidative stress and that the flavone induced nuclear
accumulation was not dependent on reactive oxygen species
(ROS).
Cell viability
Cell viability assays with apigenin and luteolin 1–100 mM were
performed in insulin sensitive HepG2 cells expressing endogenous
FOXO1, which were used for gene expression analyses. Using the
cell proliferation assay from Promega, we found significant
reductions of cell viability after 24 h only about 20% for apigenin
100 mM and 33% for luteolin 100 mM. Up to 50 mM of both
flavones cell survival rates were not affected (Table 2). With
resveratrol similar survival rates were obtained (data not shown).
Gene expression
Profiling of gene-expression was performed in human hepatoma
cells HepG2 in order to obtain data for the gluconeogenic
enzymes PEPCK and G6Pc expressed in liver as well as lipogenic
enzymes FASN and ACC. HepG2 cells were treated 2 h and 24 h
with apigenin and luteolin, RNA extracted and reverse transcribed
for qRT-PCR with specific primer-pairs shown in table 1. Gene
regulation was calculated as ratio of mRNA expression normalized
to RPL32 after treatment with specific substances versus mock
treated cells with the substance solvent.
Gluconeogenic gene regulation
PEPCK mRNA was down-regulated by flavones in a dose
dependent manner after 2 h with an IC50 of 3.2 mM for apigenin
and 5.2 mM for luteolin (Fig. 6A). After 24 h the effect of
reduction was stronger for apigenin 10–100 mM resulting in a
nearly complete suppression, with a slightly elevated IC50 of 8 mM
while luteolin was less effective with an IC50 of 11 mM (Fig. 6A9).
Reduction of G6Pc mRNA could not be detected after 2 h
(Fig. 6B), but after 24 h a complete down-regulation of G6Pc
mRNA was achieved with apigenin 10–100 mM and luteolin 20–
50 mM, while 10 mM luteolin induced the G6Pc mRNA
transcription (Fig. 6B9). In contrast we found an up-regulation of
PEPCK and G6Pase gene expression by the polyphenol resver-
atrol 50 mM in a time-dependent course (Fig. 7A). PEPCK was
induced in a biphasic manner (1–4 h and 16–24 h) possibly by
SIRT1 activation of FOXO1 and a second phase induction
Figure 3. Time-dependent induction of FOXO-GFP translocation by apigenin A) and luteolin B) obtained by fluorescence-
microscopic life cell imaging. Stably transfected human osteosarcoma cells with FOXO1-GFP (U2OS-FOXO1-GFP) were incubated with apigenin
10 mM (A) and transiently transfected human hepatic cells with FOXO1-GFP (HepG2-FOXO1-GFP) were incubated with luteolin 10 mM (B), respectively,
for 1 h at 37uC in an incubation chamber connected to the inverted fluorescence microscope Axio Observer.Z1 from Zeiss. Images were taken every
minute with the filter for GFP up to 60 minutes. FOXO1-GFP translocation with nuclear accumulation of FOXO1 is shown in a time-dependent course.
doi:10.1371/journal.pone.0104321.g003
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activated by autofeedback regulation of SIRT1 expression via
FoxO1 as described by Xiong et al. [26] while G6Pc mRNA
increased continuously (4–24 h).
Lipogenic gene regulation
Treatment for 24 h with apigenin 10–100 mM reduced ACC
mRNA about 50% and FASN mRNA to 40–50% (Fig. 6C9–D9)
while treatment for 2 h had no effect (Fig. 6C–D). Luteolin elicited
similar effects between 20–30 mM (Fig. 6C9–D9). By contrast,
slight up-regulations of FASN and ACC were found 8–24 h after
application of resveratrol 50 mM (Fig. 7B).
Knockdown of modulating factors by siRNA transfection
For the investigation of mechanisms behind these differential
patterns of gene expression, we knocked down the transcription
factors FOXO1, FOXO3a which are known to induce PEPCK
and G6Pc and NRF2 as a potential modulator, and AKT as a
FOXO-inhibitor and SIRT1 deacetylase as a FOXO-activator.
HepG2 cells were transfected with siRNAs 48 h before treatment
with apigenin and luteolin each 20 mM or DMSO 0.1% for 24 h
followed by extraction of RNA for quantitative RT-PCR. The
knockdown effects of each set of siRNAs normalized to
NonTarget-siRNA are summarized in Table 3 shown as percent-
age of each mRNA expression 6 SEM (n$4).
Gene expression profiling was performed in the presence of
non-targeting NT siRNA transfection, with 5 specific single and 6
combined double knockdowns. The effects of apigenin and
luteolin were measured versus DMSO mock stimulation in
HepG2 cells after 12 different siRNA transfection conditions
each. The next section reports our results on i) Effects of siRNAs
on gene expression and ii) Flavone effects upon Non Target and
specific siRNA knockdowns.
PEPCK
i) Effects of siRNAs on gene expression: PEPCK mRNA
levels were reduced significantly upon knockdowns of FOXO1
(p= 0.002), FOXO1/FOXO3a (p= 0.009), and FOXO1/SIRT1
(p = 0.013) indicating a clear dependence of the PEPCK expres-
sion on the transcription factor FOXO1. These effects may be
explained by a FOXO1-dependent expression of PEPCK. The
reduction of PEPCK mRNA was abolished in combined
knockdowns of FOXO1/AKT while AKT single knockdowns
resulted in slightly elevated expression. This underlines the role of
FOXO1 which would be less inactivated by phosphorylation at
serine 256 upon AKT knockdown. Knockdowns of NRF2/AKT
and NRF2 induced the PEPCK expression slightly and NRF2/
FOXO1 resulted in unchanged PEPCK mRNA levels thus
preventing the reduction observed upon FOXO1 knockdown
(Fig. 8A).
ii) Flavone effects upon Non Target and specific siRNA
knockdowns: Apigenin 20 mM suppressed PEPCK mRNA
significantly (p,0.001) after 24 h in NT siRNA transfected
HepG2 controls. Significant reductions by apigenin were found
also upon knockdowns of FOXO1 (p,0.001), FOXO3a (p,
0.001), FOXO1/FOXO3 (p= 0.002), SIRT1 (p,0.001),
FOXO1/SIRT1 (p = 0.003), AKT (p= 0.04), and FOXO1/
AKT (p= 0.005). This indicated that the apigenin induced
down-regulation of the PEPCK expression did not depend on
FOXO1, FOXO3a, SIRT1, and AKT. Upon NRF2-knockdown
and combinations NRF2/FOXO1 and NRF2/AKT significances
were lost although the apigenin induced suppression was still
apparent. Apigenin obviously exerts quite powerful effects and the
loss of significance indicates an involvement of NRF2, FOXO1
and AKT related pathways.
Figure 4. Time-dependent FOXO-GFP translocation induced by apigenin and reversed by insulin. Stably transfected human
osteosarcoma cells with FOXO1-GFP (U2OS-FOXO1-GFP) were treated with apigenin 10 mM up to 1 h 2/+ addition of insulin 100 nM after
30 minutes. Cells were fixed at indicated time points. GFP-ratio nucleus/cytoplasm was normalized to control at 0 minutes. Apigenin induced a
significant FOXO1 nuclear translocation within 5–60 minutes of stimulation with maximal nuclear accumulation after 30 minutes. This accumulation
was completely reversed by insulin during an incubation period from 30–60 minutes by competing export from nuclei into cytoplasm induced via
the insulin signaling cascade. Experiments were performed in quadruplicates for each time interval and treatment condition. Cells were fixed and
stained with DAPI for defining nuclear areas. Fluorescence microscopic analyses were performed in BD Pathway 435 system with BD Attovision using
segmentation of cells by Cyto-Nuc Ring Band, quantification of GFP intensities measured in nuclear and cytoplasmic areas. The calculation of the GFP-
ratios nucleus/cytoplasm were performed by BD Image Data Explorer. Results are presented as means of ratios normalized to control (0 minutes) 6
SEM of 3 independent treatments. Significances versus control are shown for apigenin and insulin induced time dependent translocation of FOXO1
analyzed by Oneway ANOVA with Post Hoc Dunnett T3 and Bonferroni, respectively *(p,0.05).
doi:10.1371/journal.pone.0104321.g004
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Figure 5. FOXO1-GFP translocation induced by apigenin and luteolin in the presence of N-acetyl-L-cysteine, reduced reversion by
insulin. Stably transfected human osteosarcoma cells with FOXO1-GFP (U2OS-FOXO1-GFP) were incubated with the antioxidant N-acetyl-L-cysteine
(NAC) 5 mM and 25 mM for 30 minutes before treatment with apigenin 30 mM and luteolin 30 mM 2/+ insulin 100 nM for 2 h and 24 h respectively.
Cells were fixed and stained with DAPI. Experiments were performed in quadruplets and fluorescence microscopic analyses performed with the BD
Pathway 435 system, BD Attovision and BD Image Data Explorer. GFP-ratios nucleus/cytoplasm were normalized to untreated control cells. Results are
presented as relative FOXO1 translocations resulting from means of ratios GFP Nuc/Cyt normalized to control 6 SEM. Oneway ANOVA and Dunnett
T3 significances are shown *(p,0.05), **(p,0.01), and ***(p,0.001) in blue for flavone induced FOXO1 nuclear accumulation vs control DMEM, in red
for insulin induced FOXO1 export into cytoplasm, and in yellow for NAC effect on FOXO1 translocation.
doi:10.1371/journal.pone.0104321.g005
Table 2. Cell proliferation assay.
Cell vitality [%] vs control [0 mM] ± SEM (n=3)
flavone-concentration Apigenin Luteolin
0 mM 100.0061.40 100.0061.40
1 mM 102.6561.36 103.8861.72
2 mM 99.7061.02 100.3561.03
5 mM 93.8462.36 97.2961.86
10 mM 89.2864.56 87.8061.34
20 mM 83.6561.50 102.6261.20
50 mM 82.0862.57 98.6760.58
100 mM *79.5161.80 ***66.9261.69
Oneway ANOVA p= 0.000 p= 0.000
Levene statistic p = 0.029 p= 0.159
*p,0.05 Dunnett T3 ***p,0.001 Bonferroni
Vitality of HepG2 cells treated with apigenin and luteolin 1 mM–100 mM for 24 h.
HepG2 survival was measured using the CellTiter96 Aqueous ONE Solution from Promega applied to cell-cultures after 24 h treatment with flavones apigenin and
luteolin in the range from 1–100 mM. Following incubation with 20 mM (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy phenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner
salt (MTS)/phenazine methosulfate (PMS - electron coupling reagent) for 4 h at 37uC, the optical density of the MTS bioreduction product formazan was measured at
490 nm. Means of OD-values were normalized to mock treated cells (100% survival) and analyzed by Oneway ANOVA for 0, 1, 2, 5, 10, 20, 50, and 100 mM apigenin and
luteolin respectively with Levene statistics for analyses of variance. Significant reductions of vitality were found for 100 mM apigenin or luteolin vs 0 mM in mock treated
control cells with DMSO 0.5% analyzed by Dunnett T3 (unequal variance for apigenin) or Bonferroni (equal variance for luteolin) respectively.
doi:10.1371/journal.pone.0104321.t002
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Luteolin 20 mM reduced PEPCK mRNA levels significantly
(p = 0.024) but less effectively than apigenin with significant
differences between both flavones after knockdown of FOXO1
(p= 0.004), FOXO1/FOXO3 (p= 0.009), SIRT1 (p = 0.022),
and FOXO1/AKT (p= 0.024). Luteolin down-regulated PEPCK
in the presence of FOXO3a (p = 0.005) and SIRT1 (p= 0.023)
siRNAs. Knockdowns of FOXO1, FOXO1/FOXO3a, FOXO1/
SIRT1, FOXO3a/SIRT1 abolished the inhibition by luteolin. In
the presence of NRF2 siRNA or combined NRF2/FOXO1 and
NRF2/AKT siRNAs luteolin did not show any down-regulating
effect. This indicated potential roles of FOXO1 and NRF2 in
mediating the action of luteolin. It also supports the conclusion
that NRF2 inhibits PEPCK expression as observed upon NRF2
knockdown. Apigenin was clearly more potent than luteolin as
observed in the dose response curves for inhibition of PEPCK
before (Fig. 6A). However, due to the high potency of apigenin,
the knock down results were less clear than for luteolin. We
interpret this as a consequence of the incomplete knockdown using
the siRNA technique. The remaining FOXO1 appears to be
sufficient to mediate the apigenin induced suppression of PEPCK.
The roles of FOXO3a and SIRT1 appear to be minor, however,
the combined knockdown prevented the inhibition by both
flavones, which may indicate a limited role.
G6Pc
i) Effects of siRNAs on gene expression: G6Pc mRNA
levels were reduced significantly upon knockdowns of FOXO1
(p= 0.004) and FOXO1/FOXO3a (p = 0.003). The single knock-
down of FOXO3a had no effect, exhibiting a clear dependence on
the transcription factor FOXO1 with minor contribution of
FOXO3a. The FOXO1 dependent reduction of G6Pc mRNA
was nearly abolished in combined knockdowns of FOXO1/AKT
and upon a single knockdown of AKT the expression was slightly
elevated as may be expected due to the inactivation of FOXO1
and FOXO3a via AKT. Knockdowns of NRF2 either alone or in
combination with AKT or FOXO1 slightly induced the expression
of G6Pc (Fig. 8B). Therefore deficiency of NRF2 promotes the
transcription of G6Pc as well as PEPCK indicating similar
regulation of both gluconeogenic genes.
ii) Flavone effects upon Non Target and specific siRNA
knockdowns: Apigenin 20 mM suppressed G6Pc mRNA signif-
Figure 6. Time- and dose-dependent modulation of gene
expression in HepG2 cells induced by apigenin and luteolin.
A–D: Human hepatoma cells (HepG2) were cultivated in EMEM + 10%
FBS and starved without FBS 16 h before stimulation. Apigenin and
luteolin were applied in the range of 1–100 mM diluted in EMEM.
Incubation of HepG2 was performed for 2 h and 24 h respectively. Total
RNA was extracted with Nucleospin RNA II isolation kit and reverse
transcribed with the High capacity cDNA reverse transcription kit for
quantitative realtime PCR (qRT-PCR) in triplicates using the Power SYBR
green PCR master mix with primers pairs described in Table 1. qRT-PCR
was run in triplicates using cDNA from control cells treated with DMSO
0.5% for standard dilutions. Levels of mRNA were normalized to the
houskeeping gene ribosomal protein (RPL32). Three independent
experiments were performed with different passages of HepG2. Results
are presented as fold mRNA expression normalized to control
expression as means 6 SEM and significances versus control *(p,
0.05). Gluconeogenic (A) phosphoenolpyruvate carboxykinase (PEPCK)
and (B) glucose-6-phosphatase (G6Pc), lipogenic (C) fatty-acid synthase
(FASN) and (D) acetyl-CoA-carboxylase (ACC).
doi:10.1371/journal.pone.0104321.g006
Figure 7. FOXO targetgene-expression in HepG2 (human
hepatoma) cells modulated by polyphenolic resveratrol in a
time-dependent course. A–B: HepG2 cell cultures grown in EMEM +
FBS 10% and starved for 16 h without FBS were stimulated with
resveratrol 50 mM in 0.125% DMSO in EMEM for 1–24 h. RNA was
extracted with Nucleospin RNA II isolation kit and reverse transcribed
with the High capacity cDNA reverse transcription kit for quantitative
realtime PCR (qRT-PCR) in triplicates using the Power SYBR green PCR
master mix with primers pairs described in Table 1. Modulated mRNA
levels normalized to ribosomal protein (RPL32) housekeeping gene are
shown as fold mRNA of basal expression in mock stimulated HepG2
means 6 SEM (n= 3) of 3 independent experiments with different
passages of HepG2 with significances (t-test) versus DMSO-control *p,
0.05. (A) gluconeogenic phosphoenolpyruvate carboxykinase (PEPCK)
up-regulated by resveratrol in a biphasic manner (1–4 h and 16–24 h)
and glucose-6-phosphatase (G6Pc) with continuous increase (4–24 h),
(B) lipogenic fatty-acid synthase (FASN) and acetyl-CoA-carboxylase
(ACC) slight induction 8–24 h and 16–24 h respectively.
doi:10.1371/journal.pone.0104321.g007
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icantly (p,0.001) after control NT siRNA transfection. Significant
reductions were also observed in the presence of all siRNAs while
knockdown of NRF2 prevented a significant inhibition of G6Pc by
apigenin (Fig. 8B). Luteolin 20 mM reduced G6Pc mRNA
significantly after transfection of NT siRNA (p= 0.003), SIRT1
siRNA (p= 0.047) and SIRT1/FOXO1 siRNAs (p = 0.008).
However, any combination including NRF2 prevented the
down-regulation of G6Pc by luteolin indicating a significant role
of NRF2. The down-regulation of G6Pc by luteolin was less
effective than by apigenin differing significantly in NT (p= 0.035),
upon FOXO1- (p= 0.022) and FOXO1/AKT-knockdowns
(p = 0.004). These differences possibly depend on the lower
potency of luteolin than of apigenin for the down-regulation of
G6Pc (see figure 6B dose response).
FASN. FASN mRNA levels were reduced slightly but not
significantly after transfection of FOXO1-, AKT-, NRF2-, AKT/
FOXO-, NRF2/FOXO-, and NRF2/AKT-siRNAs versus NT-
siRNA (Fig. 8C). Apigenin 20 mM reduced FASN mRNA levels
after NT siRNA (p= 0.021) and after FOXO1 siRNA (p= 0.012).
This reduction was abolished in double knockdowns of AKT/
FOXO1, NRF2/FOXO1, and NRF2/AKT indicating some
contribution of AKT and NRF2 to the down-regulation of FASN
by apigenin (Fig. 8C). NRF2 again appears to be involved in the
inhibitory effect of apigenin on metabolic enzyme expression. For
luteolin 20 mM significant down-regulations were not detected in
siRNA transfected HepG2 cells in contrast to data in untransfected
cells (see figure 6C9).
ACC. ACC mRNA levels were not significantly affected by
any of the knockdowns (Fig. 8D). Only slight reductions were
observed following AKT-, NRF2-, and combined siRNA trans-
fections similar to FASN-mRNA levels. Apigenin 20 mM and
luteolin 20 mM reduced ACC mRNA levels significantly in NT
siRNA control (p = 0.014 and p=0.008 respectively) and after
FOXO1 siRNA (p= 0.003 and p= 0.023). Upon the double
knockdown of FOXO1/FOXO3a only the down-regulation by
luteolin was significant (p = 0.039). The efficiencies of apigenin and
luteolin induced ACC regulations did not differ significantly
(Fig. 8D).
Effects of flavones on intracellular signaling pathways
For analyses of the influence of flavones on the phosphorylation
status of proteins, HepG2 cells were treated after 16 h starvation
with apigenin 20 mM, luteolin 20 mM or DMSO 0.1% for mock
stimulation for 309 with and without preincubation for 159 with
insulin 100 nM. Analyses were performed for phosphorylated
AKT(Thr308), AKT(Ser473), PRAS40(Thr246), mTOR(-
Ser2448), p70S6K(Thr389), and in duplicates.
Phosphorylation of AKT at threonine 308 and serine 473 was
significantly induced by insulin 100 nM. Both flavones apigenin
20 mM and luteolin 20 mM added 159 after insulin reversed the
AKT phosphorylation during the following 309 and reduced the
basal phosphorylation of AKT (Fig. 9A+B).
The proline-rich AKT/PKB substrate 40 kDa (PRAS40) was
phosphorylated at threonine 246 significantly by insulin relieving
PRAS inhibition of mTOR in the complex mTORC1. Apigenin
20 mM and luteolin 20 mM reduced not only the insulin induced
phosphorylation but also the basal phosphorylation status of
PRAS40 (Fig. 9C). Regarding the mammalian target of rapamycin
mTOR phosphorylation levels at serine 2448 we did not detect
any significant modulations neither by insulin nor by the flavones
apigenin or luteolin despite a slight reduction in all conditions
versus DMSO mock stimulation (Fig. 9D).The phosphorylation of
the p70S6 kinase at threonine 389 was induced by insulin 100 nM
and reversed by apigenin 20 mM to the level without insulin and
Table 3. siRNA-knockdown.
si RNAs FOXO1 mRNA FOXO3a mRNA SIRT1 mRNA AKT mRNA NRF2 mRNA
NonTarget control 100.0067.10 100.0064.98 100.0064.13 100.0063.84 100.0064.74
FOXO1 **48.49±3.73 91.2165.81 111.0069.43 94.7166.64 109.8867.57
FOXO3a 97.18614.17 ***25.85±4.87 114.22610.72 89.0869.15 112.3068.52
SIRT1 103.1869.36 100.2064.44 *50.70±10.33 90.3365.85 116.83614.49
AKT 95.23616.98 106.22618.20 112.00610.50 **36.08±6.68 116.5068.64
NRF2 94.75610.34 101.00611.87 108.1065.40 101.7068.46 **50.76±3.89
FOXO1+FOXO3a *55.15±5.92 ***38.50±3.79 120.35614.42 101.3868.93 121.98612.45
FOXO1+SIRT1 63.80±5.99 101.1060.86 *51.23±4.58 97.6365.77 129.98611.00
FOXO1+AKT 61.67±8.53 86.8568.72 104.4068.25 *41.72±7.36 95.3068.28
FOXO1+NRF2 65.57±6.53 95.65610.70 101.65610.33 88.78610.37 **52.60±5.17
FOXO3a+SIRT1 99.2062.19 ***41.48±4.07 *53.98±5.37 91.1362.19 112.2564.88
NRF2+AKT 84.43611.25 103.23624.09 94.6062.25 ***47.92±3.90 ***55.30±2.63
Oneway ANOVA p=0.000 p= 0.000 p= 0.000 p= 0.000 p= 0.000
Levene statistic p = 0.027 p= 0.002 p= 0.100 p= 0.030 p= 0.022
* P,0.05 Dunnett T3
**p,0.01 Dunnett T3
***p,0.001 Dunnett T3 * p,0.05 Bonferroni * P,0.05 Dunnett T3
**p,0.01 Dunnett T3
***p,0.001 Dunnett T3
**p,0.01 Dunnett T3 ***p,
0.001 Dunnett T3
Values: mRNA expression mean [%] 6 SEM of NonTarget control (n$4).
Knockdown by specific siRNA pools transfected with D4 (Dharmacon transfection reagent) in HepG2 cells. Single knockdowns were performed for FOXO1, FOXO3a,
SIRT1, AKT, or NRF2 (n = 8) and double knockdowns for combinations FOXO1/FOXO3a, FOXO1/SIRT1, FOXO1/AKT, FOXO1/NRF2, FOXO3a/Sirt1 or NRF2/AKT (n = 4) using
each half of the amount of siRNA used in transfection-mixes. 48 h after transfection of cells including a starvation period of 16 h in EMEM without FBS, HepG2 cells were
treated with DMSO 0.5% for 24 h (mock stimulation), RNA extracted, reverse transcribed and qRT-PCR performed with primers given in table 1. Quantified relative
amplification vs housekeeping gene RPL32 expression was normalized to the rate in HepG2 transfected with non-target NT siRNA (100% rate of expression).
doi:10.1371/journal.pone.0104321.t003
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by luteolin reduced even to a lower level of p70S6K (Thr389)
indicating a significantly stronger effect of luteolin (Fig. 9 E). The
basal phosphorylation in mock stimulated HepG2 cells was
significantly reduced upon apigenin and luteolin indicating
dephosphorylating activities.
IGF-1 receptor phosphorylation
The dose-dependent phosphorylation of the IGF-1 receptor
(IGF-1R) induced by IGF-1 in human embryonic kidney (HEK)
cell cultures overexpressing IGF-1R analyzed with the kinase
receptor activation assay (KIRA) was not influenced by apigenin
20 mM indicating a direct regulation of the PKB/AKT-signaling
pathway distal to the IGF-1 receptor (Fig. 10).
Discussion
FOXO1 is an important metabolic regulator which is inacti-
vated by insulin. Physiologically it regulates metabolism in the
fasting state and under caloric restriction when insulin levels are
low [18]. FOXO transcription factors appear to orchestrate many
of the beneficial responses to caloric restriction and may therefore
represent an interesting target for improving metabolism in the
presence of obesity and increased insulin levels. Polyphenols were
proposed to mediate the protective effects of Mediterranean diets
[11]. We therefore screened for plant derived polyphenols
activating FOXO1 by use of a GFP-tagged FOXO1 screening
assay. Remarkably, plant polyphenols contain many potent
activators of FOXO1 and we further studied the mechanism of
action of the two most potent activators identified, apigenin and
luteolin. FOXO1 is known to induce hepatic glucose production
by inducing the transcription of PEPCK and G6Pc which should
be disadvantageous for prevention of T2DM. We therefore further
focused on the regulation of the gluconeogenic and lipogenic
enzymes by luteolin and apigenin.
Our results showed the potent and rapid translocation of
FOXO1 by both flavones and its reversibility in the presence of
insulin which is well explained by their inhibition of the AKT
pathway. This inhibition is located somewhere upstream of AKT
but below the level of the insulin/IGF-1 receptor. Since these
effects occurred within minutes it implies that these flavones would
mildly antagonize insulin actions upon food intake in a competitive
manner. It also emphasizes that FOXO shuttling between nucleus
and cytoplasm is a highly dynamic process. Polyphenol actions are
often attributed to their antioxidative potential. We therefore
examined whether the effects of the flavones were related to
oxidative stress. This was obviously not the case since treatment
with an antioxidant did not alter the ability of either flavone to
translocate FOXO1. Remarkably, the activity of insulin to export
FOXO1 was impaired in the presence of antioxidants corre-
sponding to the well known regulation of redox mechanisms by
insulin [27]. The inhibition of the AKT pathway by flavones has
been previously described in HL60 and other cell types [28].
We further studied the regulation of gluconeogenic and
lipogenic enzymes in the human hepatoma cell line HepG2.
The polyphenol resveratrol which also induced nuclear transloca-
tion of FOXO1 induced the expression of PEPCK and G6Pc as
expected. By contrast, the flavones inhibited the expression of
Figure 8. Gene expression profiling upon siRNA knockdowns and analysis of modulations by apigenin and luteolin. A–D:
Subconfluent human hepatoma cells (HepG2) were transfected with silencing RNA (siRNA) for forkhead box transcription factor O1 (FOXO1), forkhead
box transcription factor O3a (FOXO3a), sirtuin1 (SIRT1), protein kinase B (PKB/AKT), nuclear factor (erythroid-derived2)-like2 (NRF2) and non targeting
(NT)-siRNA with DharmaFECT4 in EMEM + 10% FBS for 48 h including a starvation period without FBS of 16 h preceeding stimulation with apigenin
and luteolin each 20 mM for 24 h. RNA was extracted, reverse transcribed and cDNA from control cells after treatment with DMSO 0.1% were used for
standard dilutions. For 14 targets qRT-PCR was run with SYBR green in triplicates. Levels of mRNA were normalized to the expression of houskeeping
ribosomal protein (RPL32) mRNA. At least four experiments (n = 4–8) transfecting each siRNA or combined siRNAs for single and double knockdowns
and control transfections with NT-siRNA followed by apigenin, luteolin or mock treatment with DMSO 0.1% were performed with different passages
of HepG2. Ratios of mRNA levels vs basal expression in NT-siRNA transfected cells were calculated for knockdown induced fold mRNA of basal levels
(grey columns). T-tests were performed for independent samples and significances versus control are shown #p,0.05, ## p,0.01 and ###p,0.001
according to Levene statistics for equality of variances with corrections for equal variances. Expression profiles are shown for DMSO mock stimulation
(grey) apigenin 20 mM (blue) and luteolin 20 mM (red) + SEM and significant differences upon each knockdown condition obtained by Oneway
ANOVA and posthoc tests with multiple comparisons Dunnet T3 for Levene unequal or Bonferroni for Levene equal variances indicated as *p,0.05,
**p,0.01 and ***p,0.001 (blue apigenin vs DMSO, red luteolin vs DMSO, purple apigenin vs luteolin). (A) phosphoenolpyruvate carboxykinase
(PEPCK)-, (B) glucose-6-phosphatase (G6Pc)-, (C) fatty-acid synthase (FASN)-, (D) acetyl-CoA carboxylase (ACC).
doi:10.1371/journal.pone.0104321.g008
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PEPCK and G6Pc dose and time dependently. A down-regulation
of gluconeogenic gene expression over a wide range of flavone
concentrations is observed for the first time. Remarkably, PEPCK
was reduced already after 2 h while the inhibition of PEPCK was
apparent after 24 h indicating some differences in the mechanisms
involved. The lipogenic enzymes FAS and ACC were also both
down regulated by the flavones although with lower potency and a
latency of 24 h.
In a next step we analyzed the role of the transcription factors
FOXO1, FOXO3 and NRF2 in the regulation of the gluconeo-
genic enzymes and additionally the kinase AKT and the sirtuin
deacetylase SIRT1 using siRNA technology to reduce their
expression. The knock down of FOXO1 reduced the mRNA
expression levels of PEPCK and G6Pc confirming its role in
HepG2 cells. Neither FOXO3A, NRF2 nor SIRT1 or AKT knock
down had significant effects on basal expression. We also tested
double knock downs to search for interactions of the transcription
factors. As expected, the combined knock down of FOXO1 and
FOXO3a or FOXO1 and SIRT1 did not alter the inhibitory
action of FOXO1 knockdown on PEPCK-expression. However,
knock down of NRF2 completely prevented the effect of FOXO1
on the expression of PEPCK and G6Pc. To explain these NRF2
effects we analyzed the promoter sequence of human PEPCK
(2000 bp of 59UTR derived from NG_008205 for PCK1 on
chromosome 20 analyzed by Genomatix Matinspector using the
matrix family library for core/matrix similarity) and found 10
binding motifs for NRF2 (ARE Matrix family V$AP1R for MAF
and AP1 related factors), the last one near to the transcription start
site close to the FOXO1-binding site IRE2 described by Park et al.
2010 [29]. This suggests that NRF2 has potential direct effects on
the expression of PEPCK and apparently antagonizes the
inhibition by FOXO1. We postulate that a reduced availability
of NRF2 (knockdown see Table 3) for binding to ARE could
alleviate binding of FOXO to the IRE and thereby promote
PEPCK transcription. PEPCK mRNA levels were lowered upon
double knockdowns of FOXO3a/SIRT1 (p = 0.049) but FOXO3a
Figure 9. Posttranslational phosphorylation in the AKT-signaling cascade. A–E: Modifications of molecules at nodal points of AKT
intracellular signaling were analysed in lysates of human hepatoma (HepG2) cells treated with apigenin 20 mM, luteolin 20 mM or DMSO 0.1% for 309
6 pretreatment with insulin 100 nM for 159. Cell lysis was performed in presence of phosphatase inhibitors and lysates analyzed for protein
phosphorylation or cleavage using the PathScan Intracellular Signaling Array Kit (fluorescent readout) from Cell Signaling technology. Data are shown
as means of integrated intensities of three independent experiments (n = 3) + SEM normalized to untreated control cells and significances shown as
# p,0.05 and ## p,0.01 vs mock stimulated HepG2 with DMSO 0.1% (T-Test) or * p,0.05, ** p,0.01 and ***p,0.001 as indicated (Oneway
ANOVA and posthoc Bonferroni or Dunnett T3 multiple comparisons). (A) protein kinase B PKB/AKT (Thr308), (B) AKT (Ser473), (C) proline-rich AKT/
PKB substrate 40 kDa PRAS40 (Thr246), (D) mammalian target of rapamycin mTor (Ser2448), (E) p70S6 kinase p70S6K (Thr389), (F) ribosomal protein
S6 (Ser235/236).
doi:10.1371/journal.pone.0104321.g009
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alone did not show any effect and a faint reduction by SIRT1
knockdown failed to reach significance. Lower levels upon
knockdown of SIRT1 indicate some contribution of nuclear
deacetylase activity. Therefore a role of FOXO3a on PEPCK
transcription could not be confirmed and some contribution of
SIRT1 via intranuclear deacetylation appeared to enhance the
PEPCK expression. Comparing the gluconeogenic gene expres-
sion of PEPCK and G6Pc, our findings suggested that FOXO1
was one important transcription factor for both and FOXO3a
played a minor role. Higher levels of expression upon knockdowns
of AKT underline the role of FOXOs with reduced inactivating
phosphorylation capacity by AKT.
Lipogenic gene expressions for FASN and ACC in HepG2 did
not depend on FOXO1, FOXO3a and SIRT1. Both mRNA
levels were slightly reduced upon AKT- and NRF2 knockdown
leading to the assumption of a partial dependence on the
transcription factor NRF2.
We then tested the efficacy of the flavones in the presence of the
knockdowns. The reduction of PEPCK- and G6Pc-mRNA by the
flavones was not reduced by FOXO1 knock down. This
independence was expected since FOXO1 is known to induce
PEPCK. The induction of PEPCK by a known inducer of
FOXO1 was confirmed in our HepG2 cells since resveratrol
induced PEPCK as expected (see figure 7A). Since the flavones
also evoked a nuclear translocation of FOXO1 some additional
factors must have altered the effects on the expression of PEPCK
resulting in reduced mRNA levels. The inhibitory action was
abolished in the knock downs of NRF2, as was already observed
for the basal gene expression. The role of NRF2 was similar for
PEPCK and G6Pc basal transcription levels and down-regulations
by the flavones luteolin and apigenin. We therefore conclude that
the interaction of NRF2 with FOXO1 most likely explains the
inhibitory effects on the expression of PEPCK and G6Pc. NRF2 is
activated by numerous xenobiotics and oxidative stress and was
shown to improve hepatic defense mechanisms against metabolic
injuries such as high fat diets [30].
A significant down-regulation of gluconeogenic and lipogenic
gene expression by apigenin and luteolin in cells from human liver
carcinomas (similar results were obtained in parallel experiments
with HUH-7 cells, data not shown) make these flavones good
candidates for lowering hepatic glucose production (antidiabetic
effect) and reducing hepatic steatosis. The consequence of
preventing glucose production e.g. by flavone-rich diets during
insulin resistance and diabetes offers new possibilities for
regulating glucose homeostasis.
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Figure 10. Effect of apigenin on the auto-phosphorylation of the IGF-1 receptor. Human embryonic kidney (HEK) cells overexpressing the
insulin-like growth factor receptor (IGF-1R) were incubated with different concentrations of IGF-1 in the presence or absence of apigenin 20 mM for
16 minutes. Stimulated cells were lysed and transferred to a normal ELISA-sandwich assay using a mouse monoclonal IGF-1R antibody as a capture
antibody and anti-mouse horseradish peroxidase-conjugated anti-phosphotyrosine monoclonal antibody as a detection antibody to quantify the
phosphorylation of IGF-1 receptor. Bars show means 6 SEM of two experiments performed in duplicate.
doi:10.1371/journal.pone.0104321.g010
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